TuHURA BIOSCIENCES, INC./NV Adjustments to Additional Paid in Capital, Warrant Issued
TuHURA BIOSCIENCES, INC./NV (HURA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $53.01 thousand for the 12-month period ending 2017-06-30, per its 8-K filed 2019-06-03.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2019-06-03
- TuHURA BIOSCIENCES, INC./NV adjustments to additional paid in capital, warrant issued for the quarter ending 2013-09-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV adjustments to additional paid in capital, warrant issued for the quarter ending 2013-06-30 was $0.00.
- TuHURA BIOSCIENCES, INC./NV adjustments to additional paid in capital, warrant issued for the quarter ending 2013-03-31 was $2.20M.
- TuHURA BIOSCIENCES, INC./NV adjustments to additional paid in capital, warrant issued for fiscal 2016 was $3.60M, a 268.82% increase from fiscal 2015.
- TuHURA BIOSCIENCES, INC./NV adjustments to additional paid in capital, warrant issued for fiscal 2015 was $975.28K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2017-06-30 | $53.01K 8-K · filed 2019-06-03 | |||
| 2016-06-30 | $3.60M 10-K · filed 2017-09-27 | |||
| 2015-06-30 | $975.28K 10-K · filed 2016-09-13 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $0.00 derived: sum of 2 quarters · filed 2013-11-08 | $2.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $2.20M 10-Q · filed 2013-08-12 | ||
| 2013-03-31 | $2.20M 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |